Feinsod Matthew 4
4 · APPLIED GENETIC TECHNOLOGIES CORP · Filed Mar 13, 2019
Insider Transaction Report
Form 4
Feinsod Matthew
Interim Chief Medical Officer
Transactions
- Award
Common Stock
2019-03-11+2,000→ 51,287 total - Tax Payment
Common Stock
2019-03-11$3.97/sh−667$2,648→ 50,620 total
Footnotes (1)
- [F1]The common stock vested immediately upon grant.